Navigation Links
StemSep Anti-Hu HLA-DR Tetramer, 200 uL from StemCell Technologies, Inc.

ProductsStemSep Anti-Hu HLA-DR Tetramer, 200 uL from StemCell Technologies, Inc.
Company StemCell Technologies, Inc.
Item StemSep Anti-Hu HLA-DR Tetramer, 200 uL
Price 
Description When added to either StemSep CD4+ or CD8+ T Cell Enrichment cocktails, human HLA-DR TAC is designed to deplete human HLA-DR from samples to isolate resting CD4+ or CD8+ T cells.
Info StemCell Technologies, Inc.StemCell Technologies, Inc.
570 West Seventh Avenue, Suite 400
Vancouver, BC, V5Z 1B3
Canada
Customer Service:
(604) 877-0713
(800) 667-0322

Fax Number:
(604) 877-0704
(800) 567-2899

Web Site: http://www.stemcell.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. StemSep Hu-Mu Chimera Starter Kit, Kit from StemCell Technologies, Inc.
2. StemSep CD45RA Tetramer, 100 uL from StemCell Technologies, Inc.
3. StemSep Anti-Human CD69 Tetramer, 200 uL from StemCell Technologies, Inc.
4. StemSep anti-Hu TCR alpha beta, 200 uL from StemCell Technologies, Inc.
5. StemSep Anti-Hu HLA-DR Tetramer, 100 uL from StemCell Technologies, Inc.
6. StemSep Rat CD4+ T Cells, 10 mL from StemCell Technologies, Inc.
7. StemSep Rhesus CD4+ T Cells, 2 mL Kit from StemCell Technologies, Inc.
8. StemSep Rhesus T Cell Purging, 2 mL Kit from StemCell Technologies, Inc.
9. StemSep Rat T Cells, 2 mL from StemCell Technologies, Inc.
10. StemSep Anti-Phycoertherin TAC, 2 mL from StemCell Technologies, Inc.
11. Mouse Anti-Human S-100 alpha/beta chain Monoclonal Antibody, Unconjugated, Clone 8B10 from Santa Cruz Biotechnology, Inc.
... XIII in both reduced and non-reduced forms. It ... or human Factor XII. Factor XIII is a ... two subunits. Factor XIII-A is the catalytic subunit ... XIII is present in plasma as an Alpha2Beta2 ...
Anti-CaM kinase II recognizes the enzymes a subunit (6) and reacts with tissue from all mammalian species tested, as well as with chicken and frog tissues....
Ca2+ Channel Ca gamma 2 Purified Anti-Mouse, Anti-Rat, Anti-Human clone Polyclonal, Isotype Rabbit Ig, 50 µl Consult technical datasheet for details....
Goat polyclonal to Centaurin alpha 2**...
Biology Products:
(Date:10/18/2014)... referred for evaluation of suspected genetic conditions, whole-exome ... percent, including detection of a number of rare ... according to a study appearing in JAMA ... with the American Society of Human Genetics annual ... coding regions of thousands of genes simultaneously using ...
(Date:10/17/2014)... To date, antidotes ... doctors are often limited to supportive therapy such as induced ... of drugs involved. So what can be done if a ... professor Jean-Christophe Leroux from the Institute of Pharmaceutical Sciences at ... "The task was to develop an agent that could eliminate ...
(Date:10/16/2014)... they are anything but sustainable: environmental damage to ... becoming increasingly evident. Despite their disadvantages, however, monocultures ... as the sole possibility of achieving higher yields ... Schmid, an ecology professor at the University of ... and forestry. After all, a new study carried ...
Breaking Biology News(10 mins):Whole-exome sequencing shows potential as diagnostic tool 2Emergency aid for overdoses 2Emergency aid for overdoses 3Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3
... Researchers at the Institute of Neurosciences at Universitat ... by the Nurr1 gene in neuron survival associated with ... of Biological Chemistry , allows scientists to study a ... between alterations in neural connections, which are known to ...
... to date, a team of more than 200 scientists from ... boost or sabotage the brain,s resistance to a variety of ... advance online edition of Nature Genetics , the study ... brain size and intelligence. "We searched for two ...
... co-led by UC Davis neurologist Charles DeCarli and conducted by ... 71 institutions in eight countries, has advanced understanding of the ... studies appear in the April 15 edition of the journal ... on a genetic analysis of more than 9,000 people, has ...
Cached Biology News:Researchers have identified a gene with a key role in neuronal survival 2International team uncovers new genes that shape brain size, intelligence 2International team uncovers new genes that shape brain size, intelligence 3Large international study finds memory in adults impacted by versions of 4 genes 2Large international study finds memory in adults impacted by versions of 4 genes 3Large international study finds memory in adults impacted by versions of 4 genes 4
(Date:10/22/2014)... , Oct. 22, 2014   Synthetic Biologics, ... novel pathogen-specific therapies for serious infections and diseases, announced ... issued a Notice of Allowance for a composition of ... C. difficile program, SYN-004. This is Synthetic ... in the U.S. and adds to the Company,s extensive ...
(Date:10/22/2014)... SAN DIEGO and HONG KONG ... an innovative rare disease therapeutics enterprise, announced today that ... joined the company as vice president, research. Dr. McKew ... research, including key leadership positions at the National Institutes ... to its acquisition by Wyeth). Dr. McKew will lead aTyr,s ...
(Date:10/20/2014)... 2014 Asterias Biotherapeutics, Inc. (NYSE MKT: ... a Notice of Grant Award (NGA) with the ... 1, 2014.  The NGA provides for the immediate ... of additional grant funds pursuant to the previously ... development of Asterias, product, AST-OPC1. The grant provides ...
(Date:10/20/2014)... , Oct. 20, 2014 PureTech ... company tackling big healthcare problems, announced today the ... round, with participation from Invesco Perpetual, a $120 ... used to drive PureTech,s existing pipeline forward and ... "PureTech has the scientific creativity to really go ...
Breaking Biology Technology:Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6